121765-67-1
Chemical Structure
[Tyr0] Gastric Inhibitory Peptide (23-42), human
- CAS No.: 121765-67-1
- Formula:C119H182N34O31
- Molecular Weight:2584.93
IUPAC Name: 3-hexylthieno[3,2-b]thiophene
SMILES: NC(CC[C@@H](C(O)=O)NC([C@H]([C@H](O)C)NC([C@H]([C@@H](C)CC)NC([C@H](CC(N)=O)NC([C@H](CC1=CN=CN1)NC([C@H](CCCCN)NC([C@@H](NC([C@H](CC(O)=O)NC([C@H](CC(N)=O)NC([C@H](CCCCN)NC([C@H](CCCCN)NC(CNC([C@H](CCCCN)NC([C@H](CCC(N)=O)NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@@H](NC([C@H](CC(N)=O)NC([C@H](C(C)C)NC([C@@H](N)CC2=CC=C(C=C2)O)=O)=O)=O)CC3=CNC4=CC=CC=C34)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC5=CNC6=CC=CC=C56)=O)=O)=O)=O)=O)=O)=O
Biological Activity: [Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
[Tyr0] Gastric Inhibitory Peptide (23-42), human | [Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. LaPelusa A, et al. Biochemistry, Bombesin[M]//StatPearls [Internet]. StatPearls Publishing, 2021.
- [2]. K Miyawaki, et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14843-7. [Content Brief]